Activation of Wnt signaling promotes olaparib resistant ovarian cancer-Reference-Cited by-同舟云学术

Activation of Wnt signaling promotes olaparib resistant ovarian cancer

Published:2019-06-10 Issue:10 Volume:58 Page:1770-1782
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Yamamoto Tomomi M.¹,McMellen Alexandra²,Watson Zachary L.¹,Aguilera Jennifer¹,Ferguson Rebecca³,Nurmemmedov Elmar⁴,Thakar Tanay⁵,Moldovan George‐Lucian⁵^ORCID,Kim Hyunmin⁶,Cittelly Diana M.³,Joglar Annette M.¹,Brennecke Elyse P.¹,Wilson Heidi¹,Behbakht Kian¹^ORCID,Sikora Matthew J.³^ORCID,Bitler Benjamin G.¹^ORCID

Affiliation:

1. Division of Reproductive Sciences, Department of Obstetrics and Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado

2. Cancer Biology Graduate Program The University of Colorado Aurora Colorado

3. Department of Pathology University of Colorado Anschutz Medical Campus Aurora Colorado

4. John Wayne Cancer Center Los Angeles California

5. Department of Biochemistry and Molecular Biology The Pennsylvania State University College of Medicine Hershey Pennsylvania

6. Division of Medical Oncology, Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory Anschutz Medical Campus University of Colorado Aurora Colorado

Funder

U.S. Army Medical Command

Institut National Du Cancer

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23064

Reference48 articles.

1. Cancer statistics, 2018

2. PARP inhibitors: Clinical utility and possibilities of overcoming resistance